M
MHRA at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
MHRA takes part in 2 sessions at FoG London 2027 in London, its home city. Its sessions centre on the regulation of advanced therapy medicinal products (ATMPs), such as cell and gene therapies. They cover MHRA guidelines and clinical trial rules for these products and ways to lower risk and shorten the path to patients.
| Organization | FoG London 2027 Attendance |
|---|---|
M MHRA London, UK | |
UK regulator of medicines and medical devices, including clinical trial and marketing approvals for advanced therapies. | Talk Thu Jan 28 14:10–14:40 De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients How advanced cell and gene therapies could reach patients sooner through smarter trials, a new law allowing on-site manufacturing, and fairer research. Talk Thu Jan 28 16:40–17:10 Navigating MHRA Guidelines and Clinical Trial Regulations for ATMPs How to apply to the UK medicines regulator for a clinical trial of an advanced cell or gene therapy, with practical tips. |
Find decision makers at MHRA
Tell us what you sell and we’ll find the people at MHRA most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction